Low-Dose FCR Is a Safe and Effective Treatment Option for Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Updated Results of Project Q-Lite By Czech CLL Study Group
暂无分享,去创建一个
M. Šimkovič | M. Špaček | M. Doubek | D. Belada | Y. Brychtova | L. Smolej | T. Kozák | E. Cmunt | V. Procházka | K. Klásková | D. Adamová | M. Motyčková | I. Zygulová